Stockscreener 앱 받기
6.20
0.00%
0.00
전일 마감가:
$6.20
열려 있는:
$6.16
하루 거래량:
14,367
Relative Volume:
0.09
시가총액:
$45.40M
수익:
$7.00M
순이익/손실:
$-70.79M
주가수익비율:
-0.6398
EPS:
-9.69
순현금흐름:
$-64.34M
1주 성능:
+0.00%
1개월 성능:
-1.59%
6개월 성능:
+37.78%
1년 성능:
-2.21%
1일 변동 폭
$6.14
$6.20
1주일 범위
$6.12
$6.265
52주 변동 폭
$3.5334
$6.65
Kezar Life Sciences Inc Stock (KZR) Company Profile
명칭
Kezar Life Sciences Inc
전화
650-822-5600
주소
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
KZR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KZR
Kezar Life Sciences Inc
|
6.20 | 45.40M | 7.00M | -70.79M | -64.34M | -9.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Kezar Life Sciences Inc Stock (KZR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-17 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-10-17 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-16 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-12-08 | 개시 | Wells Fargo | Overweight |
| 2018-07-16 | 개시 | Jefferies | Buy |
| 2018-07-16 | 개시 | Wells Fargo | Outperform |
| 2018-07-16 | 개시 | William Blair | Outperform |
모두보기
Kezar Life Sciences Inc 주식(KZR)의 최신 뉴스
ETF Watch: Will OXLCG benefit from geopolitical trendsJuly 2025 Patterns & Low Drawdown Trading Techniques - baoquankhu1.vn
Growth Review: Should I hold or sell Kezar Life Sciences Inc now2025 Key Lessons & Intraday High Probability Alerts - baoquankhu1.vn
Layoff Tracker: SonomaBio Downsizes To Extend Runway - BioSpace
Sentiment Watch: Why Kezar Life Sciences Inc stock could rally in 2025Market Activity Summary & Free Technical Confirmation Trade Alerts - Bộ Nội Vụ
Published on: 2026-01-12 22:48:52 - Улправда
Kezar Life Sciences (KZR) to Discuss Zetomipzomib with FDA - GuruFocus
Kezar Life Sciences: FDA Division Grants Type C Meeting To Discuss Development Of Zetomipzomib - Nasdaq
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis - The AI Journal
Why Kezar Life Sciences Inc. stock appeals to dividend seekersMarket Movers & Stepwise Entry/Exit Trade Alerts - Улправда
Can Kezar Life Sciences Inc. stock hit record highs againTrade Performance Summary & Verified Momentum Stock Ideas - Улправда
How Kezar Life Sciences Inc. stock performs in rate cut cyclesMarket Activity Summary & Daily Chart Pattern Signal Reports - Улправда
How Kymera Therapeutics, Inc. stock performs during market volatility - ulpravda.ru
How geopolitical tensions affect Kezar Life Sciences Inc. stockBull Market Opportunities & High Yield Investment Portfolio - Улправда
Discontinued operations of Kezar Life Sciences Inc – GETTEX:2KZ0 - TradingView — Track All Markets
What drives Kezar Life Sciences Inc stock priceGap Up/Gap Down Analysis & Free High Yield Investment Strategies - Early Times
Financial Contrast: BioXcel Therapeutics (NASDAQ:BTAI) and Kezar Life Sciences (NASDAQ:KZR) - Defense World
Kezar Life Sciences (KZR) Upgraded to Buy: Here's What You Should Know - sharewise.com
Forecast Cut: Why Kezar Life Sciences Inc stock is seen as undervalued2025 Price Momentum & Daily Chart Pattern Signal Reports - Bộ Nội Vụ
Kezar Life Sciences Inc. (KZR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Kezar Life Sciences, Inc. (NASDAQ:KZR) Receives Average Recommendation of “Reduce” from Brokerages - Defense World
Kezar Life Sciences (NASDAQ:KZR) Shares Down 0.3% – Here’s Why - Defense World
Is Dhunseri Tea Industries Limiteds Business Expansion Justified by Stock ValuationInstitutional Buying Trends & Low Cost Portfolio Ideas - earlytimes.in
Is Kezar Life Sciences, Inc. overvalued or undervalued? - Markets Mojo
Return on assets % of Kezar Life Sciences Inc – GETTEX:2KZ0 - TradingView — Track All Markets
Can Kezar Life Sciences Inc. stock deliver consistent earnings growthMarket Movement Recap & Free High Return Stock Watch Alerts - Улправда
How rising interest rates impact Kezar Life Sciences Inc. stockQuarterly Portfolio Review & Fast Gain Stock Trading Tips - Улправда
How Kezar Life Sciences Inc. stock benefits from tech adoptionGap Up & Verified Swing Trading Watchlist - Улправда
How Kezar Life Sciences Inc. (2KZ0) stock trades pre earningsAnalyst Downgrade & Community Consensus Trade Signals - DonanımHaber
Will Kezar Life Sciences Inc. stock deliver better than expected guidanceQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - Улправда
Is Kezar Life Sciences Inc. (2KZ0) stock a good hedge against inflationStop Loss & Weekly Breakout Opportunity Watchlist - Улправда
Kezar Life Sciences Earnings Notes - Trefis
Reviewing Dyadic International (NASDAQ:DYAI) and Kezar Life Sciences (NASDAQ:KZR) - Defense World
Can Kezar Life Sciences Inc. (2KZ0) stock beat analyst consensusJuly 2025 Rallies & Daily Chart Pattern Signals - Newser
How Kezar Life Sciences Inc. (2KZ0) stock compares with market leadersJuly 2025 Retail & Risk Controlled Stock Pick Alerts - Newser
Kezar Life Sciences (KZR) Stock Analysis Report | Financials & Insights - Benzinga
Will Kezar Life Sciences Inc. (2KZ0) stock sustain uptrend momentumMarket Movement Recap & Fast Entry Momentum Alerts - Newser
Why analysts recommend PFL stock2025 Winners & Losers & Long-Term Growth Portfolio Plans - moha.gov.vn
Kezar Life Sciences Reports Q3 2025 Financial Results - MSN
How institutional buying supports Kezar Life Sciences Inc. stockJuly 2025 Volume & Fast Moving Market Watchlists - newser.com
How supply chain issues affect Kezar Life Sciences Inc. stockJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - newser.com
What valuation multiples suggest for Kezar Life Sciences Inc. stockJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
Top chart patterns to watch in Kezar Life Sciences Inc.Rate Cut & Fast Exit and Entry Trade Guides - newser.com
Is Kezar Life Sciences Inc. stock a safe haven assetSwing Trade & Reliable Volume Spike Trade Alerts - newser.com
Visual trend scoring systems applied to Kezar Life Sciences Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com
Is Kezar Life Sciences Inc. (2KZ0) stock a buy for dividend portfoliosMarket Weekly Review & Weekly High Conviction Ideas - newser.com
Is Kezar Life Sciences Inc. (2KZ0) stock ideal for retirement investorsTreasury Yields & Real-Time Chart Pattern Alerts - newser.com
How Kezar Life Sciences Inc. stock compares to industry benchmarksJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com
Kezar Life Sciences Inc (KZR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Kezar Life Sciences Inc 주식 (KZR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schiller Mark C. | Chief Operating Officer |
Jul 02 '25 |
Sale |
4.28 |
561 |
2,401 |
2,739 |
4.73%
0.92%
자본화:
|
볼륨(24시간):